Sugi Predict

Sugi Predict / Compounds / SCHEMBL4650237

SCHEMBL4650237

SCHEMBL4650237

Nc1cc(C(CC(=O)NCCCCc2ccccc2)NS(=O)(=O)c2ccccc2)ccc1OC(F)C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ THRB P10828 1/20 0.43
▸ ALDH1A1 P00352 4/20 0.42
▸ KMT2A Q03164 2/20 0.41
▸ HPGD P15428 1/20 0.41
▸ BDKRB1 P46663 1/20 0.39
▸ MMP2 P08253 3/20 0.39
▸ MMP9 P14780 3/20 0.39
▸ MMP1 P03956 2/20 0.39
▸ MMP3 P08254 2/20 0.39
▸ MMP7 P09237 2/20 0.39
▸ MMP13 P45452 2/20 0.39
▸ LMNA P02545 3/20 0.38
▸ TSHR P16473 1/20 0.38
▸ L3MBTL1 Q9Y468 2/20 0.38
▸ MAPT P10636 2/20 0.37
▸ MMP8 P22894 1/20 0.37
▸ MMP12 P39900 1/20 0.37
▸ MMP14 P50281 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ TRPV1 Q8NER1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4650977 0.93 ALDH1A1 (0.51) ALDH1A1KMT2ABDKRB1MMP2MMP9
SCHEMBL4650253 0.93 EEF2K (0.44) THRBALDH1A1BDKRB1
SCHEMBL4650246 0.92 ALDH1A1 (0.47) ALDH1A1KMT2A
SCHEMBL4651005 0.92 ITGB3 (0.43) THRBALDH1A1BDKRB1MMP13
Benzene SCHEMBL4651130 0.91 ALDH1A1 (0.44) THRBALDH1A1KMT2AHPGDLMNA
SCHEMBL4651099 0.89 ALDH1A1 (0.49) ALDH1A1KMT2AHPGD
SCHEMBL4651108 0.89 ALDH1A1 (0.44) ALDH1A1HPGDMAPTTP53
SCHEMBL4651037 0.89 ALDH1A1 (0.43) THRBALDH1A1KMT2AHPGDBDKRB1
SCHEMBL4651230 0.88 ALDH1A1 (0.38) ALDH1A1BDKRB1MMP7MMP13
SCHEMBL4650361 0.87 ALDH1A1 (0.42) THRBALDH1A1KMT2AHPGDBDKRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1301474-B1 TYROSINE DERIVATIVES AS PHOSPHATASE INHIBITORS ARRAY BIOPHARMA INC (US) 2008-09-10 — — EP claimed
US-6586467-B2 Tyrosine phosphatase inhibitors useful in the treatment or prevention of Type II Diabetes Mellitus ARRAY BIOPHARMA INC. 2003-07-01 — — US claimed
EP-1301474-A2 TYROSINE DERIVATIVES AS PHOSPHATASE INHIBITORS Array Biopharma Inc. (US) 2003-04-16 — — EP claimed
US-20020040003-A1 Preparation of phosphatase inhibitors ARRAY BIOPHARMA INC. 2002-04-04 — — US claimed
WO-2002004412-A2 TYROSINE DERIVATIVES AS PHOSPHATASE INHIBITORS ARRAY BIOPHARMA INC. (US) 2002-01-17 — — WO claimed
EP-1301474-B1 TYROSINE DERIVATIVES AS PHOSPHATASE INHIBITORS ARRAY BIOPHARMA INC (US) 2008-09-10 — — EP disclosed
US-6586467-B2 Tyrosine phosphatase inhibitors useful in the treatment or prevention of Type II Diabetes Mellitus ARRAY BIOPHARMA INC. 2003-07-01 — — US disclosed
US-20020040003-A1 Preparation of phosphatase inhibitors ARRAY BIOPHARMA INC. 2002-04-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020040003-A1 Preparation of phosphatase inhibitors PTPRS, PTPRO, PTPRR THRB 733/4885ALDH1A1 446/4885KMT2A 3124/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.